Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study

BACKGROUND: Effective adjuvant therapy for osteosarcoma is necessary for improved outcomes. Previous studies demonstrated that apatinib plus doxorubicin-based chemotherapy may improve the efficacy of neoadjuvant therapy. This study aimed to clarify the effectiveness and safety of apatinib plus doxor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiaqiang, Zhang, Fan, Dong, Shuping, Yang, Yang, Gao, Fangfang, Liu, Guancong, Zhang, Peng, Wang, Xin, Du, Xinhui, Tian, Zhichao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679406/
https://www.ncbi.nlm.nih.gov/pubmed/38023239
http://dx.doi.org/10.3389/fonc.2023.1227461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679406/
https://www.ncbi.nlm.nih.gov/pubmed/38023239
http://dx.doi.org/10.3389/fonc.2023.1227461

Ejemplares similares